Lv3
246 积分 2023-05-08 加入
A systematic review of gastritis as an immune-related adverse event in clinical interventions
1个月前
已完结
2131P Adebrelimab plus apatinib in advanced esophageal squamous cell carcinoma following immune checkpoint inhibitors: Preliminary results from cohort 3 of CAP 02 study
2个月前
已关闭
Bioelectrical impedance validation studies: alternative approaches to their interpretation
3个月前
已完结
Potential prognostic value of ITPR1 in thyroid carcinoma: An integrated analysis
6个月前
已完结
Site-specific therapy guided by a 90-gene expression assay versus empirical chemotherapy in patients with cancer of unknown primary (Fudan CUP-001): a randomised controlled trial
7个月前
已完结
Sintilimab Plus Chemotherapy for Unresectable Gastric or Gastroesophageal Junction Cancer
9个月前
已完结
Neoadjuvant and adjuvant pembrolizumab plus chemotherapy in locally advanced gastric or gastro-oesophageal cancer (KEYNOTE-585): an interim analysis of the multicentre, double-blind, randomised phase 3 study
9个月前
已完结
皖公网安备34019202002308
